Topical Antibiotics and Intravitreous Injections

Phase 4

Completed

• Conditions: Intravitreous; Injections
• Interventions: Drug: gatifloxacin

• Registration Number: NCT00410891
• Lead Sponsor: Stanford University

Brief Summary

Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2006-10-02
• Study First Submitted QC: 2006-12-11
• Study First Posted: 2006-12-13
• Study Start: 2008-07
• Primary Completion: 2009-12
• Study Completion: 2009-12
• Results First Submitted: 2014-05-13
• Results First Submitted QC: 2014-05-13
• Results First Posted: 2014-06-12
• Status Verified: 2017-10
• Last Update Submitted: 2017-10-04
• Last Update Posted: 2017-11-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 129

Inclusion Criteria

• intravitreous injection

Exclusion Criteria

• antibiotic use

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
topical antibiotic	gatifloxacin	topical gatifloxacin 4 times per day

Primary Outcome Measures

Name	Time	Method
Positive Culture	Study day 1, assessed following administration of study treatment	The percentage of patients with a positive bacterial culture following administration of study treatment is presented.

Trial Locations

Locations (1)

Stanford; 🇺🇸 Stanford, California, United States